Nuber et al. [55] identified and characterized naturally occurring MAGE-C1/CT7-specific T lymphocytes in patients with melanoma expressing this CTA, suggesting a strong immunogenicity of this antigen and that MAGE-C1/CT7 could be a good candidate for immunotherapy. Here, MAGEC1 is linked to melanoma.